[1] |
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
[2] |
Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis[J]. Cell, 1990, 61(5): 759-767.
|
[3] |
Plevová P. An update on inherited colon cancer and gastrointestinal polyposis[J]. Klin Onkol, 2019, 32(Suppl 2): 97-108.
|
[4] |
Sultanian R, Du L, Moysey B, et al. The impact of transitioning from guaiac-fecal occult blood testing to fecal immunochemical testing in a Canadian colon cancer screening program[J]. Can Assoc Gastroenterol, 2020, 3(4): 177-184.
|
[5] |
Helsingen LM, Vandvik PO, Jodal HC, et al. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline[J]. BMJ, 2019, 367: l5515.
|
[6] |
Buskermolen M, Cenin DR, Helsingen LM, et al. Colorectal cancer screening with faecal immunochemical testing, sigmoido scopy or colonoscopy: a microsimulation model ling study[J]. BMJ, 2019, 367: l5383.
|
[7] |
Li W, Chen Z, Chen H, et al. Establish a novel model for predicting the risk of colorectal ademomatous polyps: a prospective cohort study[J]. J Cancer, 2022, 13(10): 3103-3112.
|
[8] |
Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al. Estrogen plus progestin and colorectal cancer in postmenopausal women[J]. N Engl J Med, 2004, 387(9): 991-1004.
|
[9] |
Aslam MN, Paruchuri T, Bhagavathula N, et al. A mineral-rich red algae extract inhibits polyp formation and inflammation in the gastrointestinal tract of mice on a high-fat diet[J]. Integr Cancer Ther, 2010, 9(1): 93-99.
|
[10] |
Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insulin resistance[J]. Gastroenterology, 2007, 132(6): 2169-2180.
|
[11] |
Na L, Lu B, Luo CY, et al. Incidence, mortality, survival, risk factor and screening of colorectal cancer: a comparison among China,Europe, and northern America[J]. Cancer Letters, 2021, 522: 255-268.
|
[12] |
Akter S, Islam Z, Mizoue T, et al. Smoking and colorectal cancer: A pooled analysis of 10 population-based cohort studies in Japan[J]. International Journal of Cancer, 2021, 148(3): 654-664.
|
[13] |
Botteri E, Borroni E, Sloan EK, et al. Smoking and colorectal cancer risk, overall and by molecular subtypes: a Meta-analysis[J]. Am J Gastroenterol, 2020, 115(12): 1940-1949.
|
[14] |
Jacobs ET, Martinez ME, Alberts DS, et al. Association between body size and colorectal adenoma recurrence[J]. Clin Gastroenterol Hepatol, 2007, 5(8): 982-990.
|
[15] |
Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp prevention trial study group[J]. N Engl J Med, 2000, 342(16): 1149-1155.
|
[16] |
Shin HS, Cho YJ. Insulin levels are associated with risk of colon adenoma and not nonadenomatous polyps: a retrospective hospital-based study[J]. Medicine (Baltimore), 2022, 101(34): e30200.
|
[17] |
Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ[J]. Proc Nutr Soc, 2001, 60(3): 329-339.
|
[18] |
Han X, Qian W, Liu Y, et al. Effects of age, sex and pathological type on the risk of multiple polyps: A Chinese teaching hospital study[J]. J Dig Dis, 2020, 21(9): 505-511.
|
[19] |
Cazacu SM, Săftoiu A, Iordache S, et al. Factors predicting occurrence and therapeutic choice in malignant colorectal polyps: a study of 13 years of colonoscopic polypectomy[J]. Rom J Morphol Embryol, 2021, 62(4): 917-928.
|
[20] |
Emmanuel A, Lapa C, Ghosh A, et al. Risk factors for early and late adenoma recurrence after advanced colorectal endoscopic resection at an expert Western center[J]. Gastrointest Endosc, 2019, 90(1): 127-136.
|
[21] |
Backes Y, Moons LM, van Bergeijk JD, et al. Endoscopic mucosal resection (EMR) versus endoscopic submucosal dissection (ESD) for resection of large distal on-pedunculated colorectal adenomas (MATILDA-trial): rationale and design of a multicenter randomized clinical trial[J]. BMC Gastroenterol, 2016, 16(1): 56.
|
[22] |
Saini SD, Kim HM, Schoenfeld P. Incidence of advanced adenomas at urveillance colonoscopy in patients with a personal history of colon adenomas: a meta-analysis and systematic review[J]. Gastrointest Endosc, 2006, 64(4): 614-626.
|
[23] |
Huang Y, Gong W, Su B, et al. Recurrence and surveillance of colorectal adenoma after polypectomy in a southern Chinese population[J]. J Gastroenterol, 2010, 45(8): 838-845.
|
[24] |
中华医学会消化病学分会, 中华医学会消化病学分会消化系统肿瘤协作组. 中国结直肠肿瘤综合预防共识意见(2021年,上海)[J]. 中华消化杂志, 2021, 41(11): 726-759.
|
[25] |
Hao Y, Wang Y, Qi M, et al. Risk factors for recurrent colorectal polyps[J]. Gut Liver, 2020, 14(4): 399-411.
|
[26] |
Sakamoto T, Matsuda T, Otake Y, et al. Predictive factors of local recurrence after endoscopic piecemeal mucosal resection[J]. J Gastroenterol, 2012, 47(6): 635-640.
|
[27] |
Komeda Y, Watanabe T, Sakurai T, et al. Risk factors for local recurrence and appropriate surveillance interval after endoscopic resection[J]. World J Gastroenterol, 2019, 25(12): 1502-1512.
|
[28] |
Xu J, He W, Zhang N, et al. Risk factors and correlation of colorectal polyps with type 2 diabetes mellitus[J]. Ann Palliat Med, 2022, 11(2): 647-654.
|
[29] |
Liu B, Wen P, Gu X, et al. Elevated serum triglyceride predicts recurrence of colorectal polyps in patients with advanced adenomas[J]. Lipids Health Dis, 2020, 19(1): 211.
|
[30] |
Constantin GB, Firescu D, Voicu D, et al. The importance of systemic inflammation markers in the survival of patients with complicated colorectal cancer, operated in emergency[J]. Chirurgia (Bucur), 2020, 115(1): 39-49.
|
[31] |
Chen R, Wang L, Zhao Q, et al. Platelet-to-lymphocyte ratio and C-reactive protein as markers for colorectal polyp histological type[J]. BMC Cancer, 2021, 21(1): 556.
|